Tehran University of Medical Sciences

Science Communicator Platform

Share By
Role of Non-Coding Rnas in Neuroblastoma Publisher Pubmed



Anoushirvani AA1 ; Jafarian Yazdi A2 ; Amirabadi S3 ; Asouri SA4 ; Shafabakhsh R4 ; Sheida A5, 6 ; Hosseini Khabr MS5, 6 ; Jafari A7, 8 ; Tamehri Zadeh SS9 ; Hamblin MR10 ; Kalantari L5 ; Talaei Zavareh SA11 ; Mirzaei H4
Authors

Source: Cancer Gene Therapy Published:2023


Abstract

Neuroblastoma is known as the most prevalent extracranial malignancy in childhood with a neural crest origin. It has been widely accepted that non-coding RNAs (ncRNAs) play important roles in many types of cancer, including glioma and gastrointestinal cancers. They may regulate the cancer gene network. According to recent sequencing and profiling studies, ncRNAs genes are deregulated in human cancers via deletion, amplification, abnormal epigenetic, or transcriptional regulation. Disturbances in the expression of ncRNAs may act either as oncogenes or as anti-tumor suppressor genes, and can lead to the induction of cancer hallmarks. ncRNAs can be secreted from tumor cells inside exosomes, where they can be transferred to other cells to affect their function. However, these topics still need more study to clarify their exact roles, so the present review addresses different roles and functions of ncRNAs in neuroblastoma. © 2023, The Author(s), under exclusive licence to Springer Nature America, Inc.
Other Related Docs
4. Role of Non-Coding Rnas and Exosomal Non-Coding Rnas in Retinoblastoma Progression, Frontiers in Cell and Developmental Biology (2022)
6. Non-Coding Rnas in Cancer Immunotherapy: A Solution to Overcome Immune Resistance?, Progress in Molecular Biology and Translational Science (2024)
12. Biological Function and Molecular Mechanism of Pirna in Cancer, Practical Laboratory Medicine (2019)
13. Non-Coding Rnas and Exosomal Non-Coding Rnas in Pituitary Adenoma, Pathology Research and Practice (2023)
14. Long Noncoding Rnas Biomarker-Based Cancer Assessment, Journal of Cellular Physiology (2019)